HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark Cushman Selected Research

indimitecan

1/2018Novel Fluoroindenoisoquinoline Non-Camptothecin Topoisomerase I Inhibitors.
12/2012Identification, synthesis, and biological evaluation of metabolites of the experimental cancer treatment drugs indotecan (LMP400) and indimitecan (LMP776) and investigation of isomerically hydroxylated indenoisoquinoline analogues as topoisomerase I poisons.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark Cushman Research Topics

Disease

44Neoplasms (Cancer)
12/2021 - 01/2002
12Breast Neoplasms (Breast Cancer)
11/2016 - 03/2004
9Poisoning
05/2020 - 02/2005
7Tuberculosis (Tuberculoses)
05/2010 - 03/2005
6Infections
04/2015 - 08/2008
5Leukemia
01/2018 - 01/2007
5Acquired Immunodeficiency Syndrome (AIDS)
04/2008 - 04/2006
3HIV Infections (HIV Infection)
04/2008 - 09/2005
2Visceral Leishmaniasis (Kala Azar)
12/2019 - 10/2012
2Leishmaniasis
11/2019 - 10/2012
2Carcinoma (Carcinomatosis)
01/2018 - 01/2007
2Carcinogenesis
01/2012 - 11/2008
1Communicable Diseases (Infectious Diseases)
01/2022
1Rheumatoid Arthritis
12/2018
1African Trypanosomiasis (Nagana)
11/2018
1Angelman Syndrome (Syndrome, Angelman)
01/2018
1Neurodevelopmental Disorders
01/2018
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2018
1Glioma (Gliomas)
09/2015
1Pancreatic Neoplasms (Pancreatic Cancer)
09/2015
1Shock
09/2015
1Prostatic Neoplasms (Prostate Cancer)
04/2015
1Wound Infection (Wound Infections)
01/2015
1Wounds and Injuries (Trauma)
01/2015

Drug/Important Bio-Agent (IBA)

11Type I DNA Topoisomerases (Topoisomerase I)IBA
12/2021 - 01/2002
10Biological ProductsIBA
12/2021 - 11/2004
8Topoisomerase I InhibitorsIBA
01/2018 - 12/2003
6Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 03/2005
6EnzymesIBA
01/2017 - 11/2004
6Aromatase (CYP19)IBA
01/2016 - 07/2010
66,7-dimethyl-8-ribityllumazine synthase (lumazine synthase)IBA
05/2010 - 03/2005
6CamptothecinIBA
08/2008 - 12/2003
6NucleosidesIBA
04/2008 - 09/2005
5Pharmaceutical PreparationsIBA
12/2021 - 11/2003
5Estrogen ReceptorsIBA
12/2021 - 03/2004
5Proteins (Proteins, Gene)FDA Link
05/2020 - 02/2005
5Aromatase InhibitorsIBA
11/2016 - 06/2007
4DNA (Deoxyribonucleic Acid)IBA
12/2021 - 01/2012
4TubulinIBA
10/2004 - 10/2002
3PoisonsIBA
12/2019 - 12/2012
3LactamsIBA
01/2017 - 05/2007
3Selective Estrogen Receptor Modulators (SERM)IBA
11/2016 - 03/2015
3ResveratrolIBA
09/2015 - 03/2004
3Antineoplastic Agents (Antineoplastics)IBA
03/2015 - 07/2003
3NSC 724998IBA
12/2012 - 11/2007
3Retinoid X Receptors (Retinoid X Receptor)IBA
06/2012 - 04/2011
3isoquinolineIBA
06/2012 - 07/2005
3Reverse Transcriptase InhibitorsIBA
04/2008 - 04/2006
32- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
11/2007 - 11/2003
2Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
12/2021 - 02/2008
2indimitecanIBA
01/2018 - 12/2012
2Topotecan (Hycamtin)FDA LinkGeneric
01/2018 - 01/2018
2tyrosyl-DNA phosphodiesteraseIBA
01/2017 - 05/2014
2TamoxifenFDA LinkGeneric
01/2016 - 05/2012
2Estrogens (Estrogen)FDA Link
01/2016 - 03/2004
2ProdrugsIBA
01/2016 - 06/2005
2Acetates (Acetic Acid Esters)FDA Link
09/2015 - 11/2008
23- amino- 6- (3- aminopropyl)- 5,6- dihydro- 5,11- dioxo- 11H- indeno(1,2- c)isoquinolineIBA
03/2012 - 04/2011
2Riboflavin SynthaseIBA
08/2009 - 09/2007
2zapotinIBA
11/2008 - 01/2007
2Antiviral Agents (Antivirals)IBA
08/2008 - 04/2008
2Human immunodeficiency virus 1 reverse transcriptaseIBA
02/2008 - 09/2005
26- (3- (2- hydroxyethyl)amino- 1- propyl)- 5,6- dihydro- 2,3- dimethoxy- 8,9- methylenedioxy- 5,11- dioxo- 11H- indeno(1,2- )isoquinolineIBA
02/2005 - 11/2003
22-MethoxyestradiolIBA
10/2004 - 10/2002
2lavendustin AIBA
04/2003 - 10/2002
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
12/2021
1Type II DNA Topoisomerases (Topoisomerase II)IBA
12/2021
1Gatifloxacin (Zymar)FDA Link
05/2020
1MacrolidesIBA
05/2020
1FluoroquinolonesIBA
05/2020
1Ciprofloxacin (Cipro)FDA LinkGeneric
05/2020
1Azithromycin (Zithromax)FDA LinkGeneric
05/2020
1tofacitinibIBA
12/2018
1Antiparasitic Agents (Antiparasitics)IBA
11/2018
1Therapeutic UsesIBA
01/2018
1Histones (Histone)IBA
01/2018
1Estradiol (Delestrogen)FDA LinkGeneric
01/2016
1triphenylethyleneIBA
01/2016
1NitrogenIBA
01/2016
1Sirolimus (Rapamycin)FDA Link
09/2015
1SurvivinIBA
09/2015
1Epidermal Growth Factor (EGF)IBA
09/2015
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
09/2015
1Serine (L-Serine)FDA Link
09/2015
1Tyrosine (L-Tyrosine)FDA Link
09/2015
1Cyclin D1IBA
09/2015
1CaspasesIBA
09/2015
1Cyclin B1IBA
09/2015
1ChlorineIBA
05/2015
1FluorineIBA
05/2015
1AntigensIBA
04/2015
1ThiazolesIBA
01/2015
1Mupirocin (Bactroban)FDA LinkGeneric
01/2015
1Methicillin (Metin)FDA Link
02/2014
17-azaindenoisoquinolineIBA
02/2014
1Hormones (Hormone)IBA
09/2013
1N,N-didesmethyl-4-hydroxytamoxifenIBA
06/2013

Therapy/Procedure

6Chemoprevention
06/2012 - 06/2007
4Drug Therapy (Chemotherapy)
12/2021 - 06/2008
4Therapeutics
11/2018 - 09/2005